380223-72-3

Upstream product

• 124-63-0 methanesulfonyl chloride 
• 380223-70-1 [(4S,5R)-2-(5-Bromo-2-methoxy-phenyl)-5-methyl-4,5-dihydro-oxazol-4-yl]-methanol 
• 380223-66-5 (2R,3S)-2-(5-Bromo-2-methoxy-benzoylamino)-3-hydroxy-butyric acid methyl ester 
• 380223-68-7 (4R,5R)-2-(5-Bromo-2-methoxy-phenyl)-5-methyl-4,5-dihydro-oxazole-4-carboxylic acid methyl ester 
• 2476-35-9 5-bromo-2-methoxybenzoic acid 
• 62910-63-8 5-bromo-2-methoxybenzoyl chloride 

Relevant academic research and scientific papers

Benzamide bioisosteres incorporating dihydroheteroazole substructures: EPC synthesis and SAR leading to a selective dopamine D4 receptor partial agonist (FAUC 179)

Conformationally restricted benzamide bioisosteres were investigated when the chiral phenyldihydroimidazole derivative 4e (FAUC 179) showed strong and highly selective dopamine D4 receptor binding (Kihigh = 0.95 nM). Mitogenesis experiments indicated partial agonist properties (42%). EPC syntheses of the target compounds of type 4 were performed starting from α-amino acids.